Subscribe to RSS
DOI: 10.1055/s-0034-1370915
Liquid Chromatography/Electrospray Ionisation Tandem Mass Spectrometric Study of Sitagliptin and its Stressed Degradation Products
Publication History
received 06 November 2013
accepted 03 February 2014
Publication Date:
12 March 2014 (online)
Abstract
A sensitive UPLC positive ion electrospray tandem mass spectrometry method was developed and validated for identification of degradation products of sitagliptin formed during stress study. Six of the major degradants were identified with the proposed method. The separation of sitagliptin and its degradation products was achieved on a Acquity BEH C-18 column (50×2.1 mm, 1.7 µm) using a gradient programme. The mobile phase consists of solvent A (10 mM ammonium formate, pH 6.4 adjusted with formic acid) and solvent B (acetonitrile) and quantitative evaluation was performed at 267 nm with a flow rate of 0.15 mL min−1. Suitability of this method for the quantitative determination of the drugs was proved by validation in accordance with International Conference on Harmonization (ICH) guidelines and can be used for routine analysis of sitagliptin formulations in quality control.
-
References
- 1 Rao RN, Maurya PK, Khalid S. Development of a molecularly imprinted polymer for selective extraction followed by liquid chromatographic determination of Sitagliptin in rat plasma and urine. Talanta 2011; 85: 950-957
- 2 Nirogi R, Kandikere V, Mudigonda K et al. Sensitive liquid chromatography tandem mass spectrometry method for the quantification of Sitagliptin, a DPP-4 inhibitor, in human plasma using liquid–liquid extraction. Biomedical Chromatography 2008; 22: 214-222
- 3 El-Bagary RI, Elkady EF, Ayoub BM. Liquid chromatographic determination of Sitagliptin either alone or in ternary mixture with metformin and Sitagliptin degradation product. Talanta 2011; 85: 673-680
- 4 Ravanello A, Schreiner Delgado L, Isa Pedroso Marcolino A et al. A Simple Stability-Indicating LC-UV Method to Assay Sitagliptin Phosphate in Tablets. Current Analytical Chemistry 2012; 8: 569-573
- 5 Dubala A, Khatwal R, Kosaraju J et al. Bioanalytical method development and validation of Sitagliptin phosphate by RP-HPLC and its application to pharmacokinetic study. Int J Pharm Pharm Sci 2012; 4: 691-694
- 6 Sekaran CB, Rani AP. Development and validation of spectrophotometric method for the dtrmination of DPP-4 inhibitor, Sitagliptin, in its pharmactical preparations. Electica Quimica 2010; 35: 45-53
- 7 Sonune DP, Mahesh KM. Isolation, characterisation of degradation prodcts of sitagliptin and dvelopment of validated stability-indicating HPLC assay method for sitagliptin API and tablets. IJPSR 2013; 4: 3494-3501
- 8 Salim M, El-Enany N, Belal F et al. Micelle-enhanced spectrofluorimetric method for determination of sitagliptin and identification of potential alkaline degradation products using LC-MS. Luminescence 2013;
- 9 ICH . International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of Analytical Procedures: Text and Methodology Q2 (R1) 2005;